Page last updated: 2024-09-04

sg 209 and 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one

sg 209 has been researched along with 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one in 1 studies

Compound Research Comparison

Studies (sg 209)	Trials (sg 209)	Recent Studies (post-2010) (sg 209)	Studies (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)	Trials (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)	Recent Studies (post-2010) (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)
15	0	3	793	0	110

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Di Girolamo, N; Heywood, GJ; Thomas, PS; Wei, XM	1

Other Studies

1 other study(ies) available for sg 209 and 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one

Article	Year
Nicorandil inhibits the release of TNFalpha from a lymphocyte cell line and peripheral blood lymphocytes. International immunopharmacology, 2003, Volume: 3, Issue:12 Topics: B-Lymphocytes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Herpesvirus 4, Human; Humans; Immunoglobulin G; Leukocytes, Mononuclear; Niacinamide; Nicorandil; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Oxadiazoles; Pinacidil; Potassium Channels; Quinoxalines; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha	2003

Article

Year

Nicorandil inhibits the release of TNFalpha from a lymphocyte cell line and peripheral blood lymphocytes.

International immunopharmacology, 2003, Volume: 3, Issue:12

Topics: B-Lymphocytes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Herpesvirus 4, Human; Humans; Immunoglobulin G; Leukocytes, Mononuclear; Niacinamide; Nicorandil; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Oxadiazoles; Pinacidil; Potassium Channels; Quinoxalines; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

2003